Read our latest news below. Discover more about InnoCore and our technologies by selecting Downloads or Videos from the menu above. Select Events for upcoming dates and events where you can meet InnoCore.

InnoCore Pharmaceuticals has been awarded a grant by the Bill & Melinda Gates Foundation to develop a long-acting injectable contraceptive implant

Groningen, The Netherlands, September 11, 2020, InnoCore Pharmaceuticals, a Dutch pharmaceutical drug delivery and development...

Read more
InnoCore Pharmaceuticals to join Bill & Melinda Gates Foundation supported consortium to develop long-acting microneedle contraceptive

Groningen, The Netherlands, January 15th, 2019, InnoCore Pharmaceuticals, a Dutch pharmaceutical drug delivery and development...

Read more
Merck and InnoCore Pharmaceuticals to Improve Patient Compliance with New Drug Delivery Technology

  Groningen, The Netherlands, July 26, 2018 – InnoCore Pharmaceuticals and Merck KGaA (operating as MilliporeSigma...

Read more
InnoCore renewed the GMP certificate

Groningen, February 6th, 2018: InnoCore Pharmaceuticals renewed the GMP certificate including laboratory authorization...

Read more
InnoCore has been awarded with the "Groningen Ondernemingsprijs 2017"

Groningen, 30th November 2017. With the development of long-term active medicines, InnoCore Pharmaceuticals has won the Groningen...

Read more
Exclusive License Agreement with Allergan

Groningen, October 22, 2013: InnoCore Pharmaceuticals Enters into Exclusive License Agreement with Allergan Related to...

Read more

We use cookies for analyzing visitors behavior.